Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY-NC-NDJournal of the Saudi Heart Association

Position Statement by the Saudi Heart Failure Working Group of the Saudi Heart Association on the Management of Advanced Heart Failure in Saudi Arabia.

  • Ibrahim Jelaidan1,2,3
  • Abeer Bakhsh4
  • Ammar G Chaudhary5
  • Ebtisam Alkhattaby6
  • Fahmi AlKaf7
  • Feras Khaliel8
  • Ismail Raslan9
  • Mohammed Alreshidan10
  • Mosaad Alhussein11
  • Waleed Alhabeeb12
12 affiliations
  1. 1Department of Cardiac Sciences at King Faisal Cardiac Centre, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  2. 2King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
  3. 3King Saud Bin Abdulaziz University for Health Sciences, (COM-WR), Jeddah, Saudi Arabia.
  4. 4Department of Cardiology, Advanced Heart Failure, King Abdullah Medical City, Makkah, Saudi Arabia.
  5. 5Department of Advanced Heart Failure and Cardiovascular Echocardiography, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
  6. 6Department of Nursing Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  7. 7Department of Adult Cardiology, King Fahad Medical City, Riyadh, Saudi Arabia.
  8. 8Department of Cardiac Surgery, Al Faisal University, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  9. 9Department of Cardiac Sciences, College of Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.
  10. 10Department of Cardiac Surgery, King Salman Heart Center, King Fahad Medical City, Riyadh, Saudi Arabia.
  11. 11Department of Cardiology, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
  12. 12Department of Cardiac Sciences, King Saud University, Riyadh, Saudi Arabia.
Read full textPDFDOICite

Abstract

Background

Heart failure (HF) is a leading cause of morbidity and mortality in Saudi Arabia. Despite remarkable progress in guideline-directed medical therapy, a significant proportion of patients progress to advanced HF and require evaluation for heart transplantation or mechanical circulatory support (MCS). In response to this growing burden, the Saudi Heart Association (SHA) developed recommendations to guide identification, timely referral, and optimal management of candidates for advanced HF therapies in Saudi Arabia.Methods

A multidisciplinary panel of 10 HF experts from Saudi Arabia convened for a series of structured virtual meetings to review local and international evidence. The panel integrated Saudi-specific clinical practice patterns and healthcare considerations into the deliberation process. Consensus was achieved through discussion and majority agreement. Recommendations were formulated using the SHA methodology, supported by a comprehensive literature review of published evidence.Results and conclusions

The SHA consensus establishes a structured, comprehensive framework for recognizing advanced HF, optimizing guideline-directed therapy, and determining candidacy for heart transplantation or MCS in tertiary and quaternary centers in Saudi Arabia. The document emphasizes timely prognostic stratification using clinical indicators and standardized tools such as INTERMACS and SCAI classifications. Referral pathways and multidisciplinary coordination are delineated to facilitate efficient evaluation and timely intervention. These recommendations aim to minimize delays in referral, expand access to advanced HF therapies and improve patient outcomes across Saudi Arabia.

Related

  1. Management of Heart transplant recipients for the non Heart Transplant health care provider. A Clinical Consensus Statement of the Heart Failure Association (HFA) and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC
    Guillaume Baudry, Emer Joyce, Marianna Adamo +13
    European Journal of Heart FailurePeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaHAL
  2. The European Anthropological Association (EAA) position statement on anthropometry: education, competence, and scientific authority
    Stefania Toselli, Maria Kaczmarek, Noël Cameron
    Annals of Human BiologyPeer-reviewedCC BYFull textGeneral biologyPhysiologyDOAJ
  3. Management of Obesity in Special Populations and Limited-Resource Settings: An Egyptian Medical Position Statement.
    Mona A Hegazy, Amr Mattar, Maissa Mohamed Shawky +13
    Diabetes, metabolic syndrome and obesity : targets and therapyPeer-reviewedCC BY-NCFull textPharmacology & toxicologyEurope PMCPMC
  4. Management of Coronary Calcified Nodules: A Position Statement
    Yang Cao, MD, Dingyu Wang, MD, Achmad Fauzi Yahya, MD +52
    JACC: AsiaPeer-reviewedCC BYFull textMedical imaging & radiologyDOAJ
  5. Society of Interventional Radiology Position Statement on Genicular Artery Embolization for Symptomatic Knee Osteoarthritis
    Osman S. Ahmed, Bedros Taslakian, Yuji Okuno +13
    Journal of Vascular and Interventional RadiologyPeer-reviewedCC BY12 citedGeneral medicineOpenAlex

Cite

BibTeXRIS
BibTeX
@article{jelaidan2026position,
  title = {{Position Statement by the Saudi Heart Failure Working Group of the Saudi Heart Association on the Management of Advanced Heart Failure in Saudi Arabia.}},
  author = {Ibrahim Jelaidan and Abeer Bakhsh and Ammar G Chaudhary and Ebtisam Alkhattaby and Fahmi AlKaf and Feras Khaliel and Ismail Raslan and Mohammed Alreshidan and Mosaad Alhussein and Waleed Alhabeeb},
  journal = {Journal of the Saudi Heart Association},
  year = {2026},
  month = jul,
  doi = {10.37616/2212-5043.1509},
  url = {https://europepmc.org/article/MED/42899058},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Position Statement by the Saudi Heart Failure Working Group of the Saudi Heart Association on the Management of Advanced Heart Failure in Saudi Arabia.
AU  - Ibrahim Jelaidan
AU  - Abeer Bakhsh
AU  - Ammar G Chaudhary
AU  - Ebtisam Alkhattaby
AU  - Fahmi AlKaf
AU  - Feras Khaliel
AU  - Ismail Raslan
AU  - Mohammed Alreshidan
AU  - Mosaad Alhussein
AU  - Waleed Alhabeeb
PY  - 2026
DA  - 2026/07/09
JO  - Journal of the Saudi Heart Association
DO  - 10.37616/2212-5043.1509
UR  - https://europepmc.org/article/MED/42899058
AB  - Background  Heart failure (HF) is a leading cause of morbidity and mortality in Saudi Arabia. Despite remarkable progress in guideline-directed medical therapy, a significant proportion of patients progress to advanced HF and require evaluation for heart transplantation or mechanical circulatory support (MCS). In response to this growing burden, the Saudi Heart Association (SHA) developed recommendations to guide identification, timely referral, and optimal management of candidates for advanced HF therapies in Saudi Arabia.Methods  A multidisciplinary panel of 10 HF experts from Saudi Arabia convened for a series of structured virtual meetings to review local and international evidence. The panel integrated Saudi-specific clinical practice patterns and healthcare considerations into the deliberation process. Consensus was achieved through discussion and majority agreement. Recommendations were formulated using the SHA methodology, supported by a comprehensive literature review of published evidence.Results and conclusions  The SHA consensus establishes a structured, comprehensive framework for recognizing advanced HF, optimizing guideline-directed therapy, and determining candidacy for heart transplantation or MCS in tertiary and quaternary centers in Saudi Arabia. The document emphasizes timely prognostic stratification using clinical indicators and standardized tools such as INTERMACS and SCAI classifications. Referral pathways and multidisciplinary coordination are delineated to facilitate efficient evaluation and timely intervention. These recommendations aim to minimize delays in referral, expand access to advanced HF therapies and improve patient outcomes across Saudi Arabia.
SN  - 1016-7315
SN  - 2212-5043
ER  -